![Thomas Turalski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 95 323 $ au 31/08/2026
Mr. Thomas Turalski is a Portfolio Manager at Revidea Ventures LLC.
Mr. Turalski was previously employed as a Senior Analyst by Perceptive Advisors LLC, a Senior Analyst by Perceptive Advisors LLC, a Member by Acerta Pharma BV, a Principal by Exis Capital Management, Inc., and a Member-Supervisory Board by Ryvu Therapeutics SA.
He received his undergraduate degree from The Trustees of Columbia University in The City of New York.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RYVU THERAPEUTICS SA 0,09 % | 30/09/2025 | 20 100 ( 0,09 % ) | 95 323 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|
| Sociétés | Poste | Fin |
|---|---|---|
Exis Capital Management, Inc.
 Exis Capital Management, Inc. Investment ManagersFinance Exis Capital Management uses quantitative strategies to manage a multi-strategy hedge fund. The firm focuses on a variety of sectors, including but not limited to, industrial services, health technology, electronic technology, producer manufacturing and non-energy minerals, as well as high yield and distressed debt. Exis Capital Management invests long/short primarily in the stocks of US mid-cap and large-cap stocks. The firm maintains a very high turnover rate. | Corporate Officer/Principal | 31/12/2007 |
Perceptive Advisors LLC
 Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility. | Analyst-Equity | 01/01/2005 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Corporate Officer/Principal | - |
| RYVU THERAPEUTICS S.A. | Directeur/Membre du Conseil | - |
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility. | Analyst-Equity | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
Exis Capital Management, Inc.
Exis Capital Management, Inc. Investment ManagersFinance Exis Capital Management uses quantitative strategies to manage a multi-strategy hedge fund. The firm focuses on a variety of sectors, including but not limited to, industrial services, health technology, electronic technology, producer manufacturing and non-energy minerals, as well as high yield and distressed debt. Exis Capital Management invests long/short primarily in the stocks of US mid-cap and large-cap stocks. The firm maintains a very high turnover rate. | Finance |
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility. | Finance |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ryvu Therapeutics SA
 Ryvu Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops and sells therapies for precision oncology | Health Technology |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
